Bioavailability and feasibility of subcutaneous 5-fluorouracil.

[1]  S. Taylor.  Head and neck cancer. , 1991, Cancer chemotherapy and biological response modifiers.

[2]  H. Bruckner,et al.  Chemotherapy of advanced cancer of the colon and rectum. , 1991, Seminars in oncology.

[3]  K. Brunner,et al.  Bioavailability of subcutaneous ifosfamide and feasibility of continuous outpatient application in cancer patients. , 1990, Annals of Oncology.

[4]  R. Klein,et al.  Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. , 1990, Annals of internal medicine.

[5]  J G Fryer,et al.  A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. Macdonald.  Continuous low-dose infusion of fluorouracil: is the benefit worth the cost? , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  R. Pazdur,et al.  Low‐dose continuous infusion 5‐fluorouracil. Evaluation in advanced breast carcinoma , 1989, Cancer.

[8]  W. Panje,et al.  A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer , 1989, Cancer.

[9]  M. al-Sarraf.  Head and neck cancer: chemotherapy concepts. , 1988, Seminars in oncology.

[10]  J. Jacobs,et al.  A randomized trial of cisplatin (CACP) + 5‐fluorouracil (5‐FU) infusion and CACP + 5‐FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck , 1985, Cancer.

[11]  W. Ensminger,et al.  Sensitive high-performance liquid chromatographic method for the determination of 5-fluorouracil in plasma. , 1985, Journal of chromatography.

[12]  J. Jacobs,et al.  Cisplatin and 5‐fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck , 1984, Cancer.

[13]  R. Dedrick,et al.  Nonlinear pharmacokinetic models for 5‐fluorouracil in man: Intravenous and intraperitoneal routes , 1980, Clinical pharmacology and therapeutics.

[14]  V. Vaitkevicius,et al.  Comparison of continuously infused 5‐fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma , 1975, Cancer.